March 30, 2007
Merck insomnia drug put to bed
Gaboxadol was designed by Lundbeck in collaboration with Merck & Co. It aimed to relax the brain through activating a certain receptor called gamma-aminobutyric acid receptor A . However, in an event both have …
Comment
From Insomnia News